Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

SFTPG Activators

Chemical activators of SFTPG can engage distinct cellular signaling pathways to enhance its activity. Forskolin and Rolipram both raise intracellular cAMP levels, which activates protein kinase A (PKA). PKA then phosphorylates target proteins, and this phosphorylation can lead to the activation of SFTPG. Similarly, IBMX acts to increase cAMP by inhibiting phosphodiesterases which break down cAMP, thereby sustaining the activation signal for longer periods. Zaprinast follows a parallel route by inhibiting PDE5, thus increasing cGMP levels, which can activate protein kinase G (PKG). PKG, like PKA, phosphorylates serine and threonine residues on target proteins, providing a mechanism for the activation of SFTPG.

Phorbol 12-myristate 13-acetate (PMA) directly stimulates protein kinase C (PKC), which is known to phosphorylate a wide array of proteins, and this can result in the phosphorylation and activation of SFTPG. Ionomycin, by increasing intracellular calcium levels, can activate calmodulin-dependent protein kinases (CaMK), which again could lead to the phosphorylation and activation of SFTPG. Phosphatidic Acid, through its role as a second messenger, activates mammalian target of rapamycin (mTOR), which can initiate signaling cascades resulting in the phosphorylation of target proteins, thus potentially activating SFTPG. FTY720, by activating sphingosine-1-phosphate receptors, can initiate signaling cascades involving PKC, which could then phosphorylate and activate SFTPG. Additionally, Okadaic Acid and Calyculin A prevent the dephosphorylation of proteins by inhibiting protein phosphatases PP1 and PP2A, which could result in a sustained activation state of SFTPG. Finally, Anisomycin activates the stress-activated protein kinases (SAPKs), which can target and phosphorylate SFTPG, leading to its activation. Each of these chemicals activates SFTPG via a targeted phosphorylation mechanism, ensuring the protein's functional enhancement without merely increasing its expression or general protein translation.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Activates adenylyl cyclase increasing cAMP levels, which can enhance the activation of SFTPG via PKA.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

Inhibits phosphodiesterases, increasing cAMP levels and potentially enhancing SFTPG activation via PKA.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

Directly activates PKC which could lead to the phosphorylation and activation of SFTPG.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Increases intracellular Ca²⁺, potentially activating CaMK which could phosphorylate and activate SFTPG.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$285.00
$520.00
$1300.00
78
(4)

Inhibits PP1 and PP2A, preventing dephosphorylation and potentially maintaining SFTPG in an active state.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

Activates SAPKs which can phosphorylate and activate SFTPG.

Phosphatidic Acid, Dipalmitoyl

169051-60-9sc-201057
sc-201057B
sc-201057A
100 mg
250 mg
500 mg
$104.00
$239.00
$409.00
(1)

Activates mTOR, which could lead to SFTPG activation through downstream kinase phosphorylation.

FTY720

162359-56-0sc-202161
sc-202161A
sc-202161B
1 mg
5 mg
25 mg
$32.00
$75.00
$118.00
14
(1)

Activates S1P receptors that could lead to PKC activation and subsequent SFTPG phosphorylation.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$97.00
$224.00
30
(1)

Directly activates PKA, which can phosphorylate and activate SFTPG.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$103.00
$245.00
8
(2)

Inhibits PDE5 increasing cGMP levels, which can activate PKG leading to the activation of SFTPG.